MJT & Associates Financial Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
1,847
-14
-0.8% -$3.26K 0.31% 23
2026
Q1
$455K Sell
1,861
-1,155
-38% -$269K 0.33% 21
2025
Q4
$624K Sell
3,016
-30
-1% -$5.93K 0.47% 20
2025
Q3
$565K Sell
3,046
-382
-11% -$65.4K 0.46% 21
2025
Q2
$524K Sell
3,428
-16
-0.5% -$2.46K 0.65% 19
2025
Q1
$571K Buy
+3,444
New +$539K 0.55% 21

Other funds holding JNJ

MJT & Associates Financial Advisory's JNJ Position: Q2 2026 in Review

MJT & Associates Financial Advisory reduced its Johnson & Johnson (JNJ) stake by 0.75% in Q2 2026, selling an estimated $3.26K and leaving 1,847 shares worth $469K. The position accounts for 0.31% of the portfolio, ranked #23.

MJT & Associates Financial Advisory first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $624K in Q4 2025. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MJT & Associates Financial Advisory held 1,847 shares of Johnson & Johnson worth $469K as of Q2 2026.
  • MJT & Associates Financial Advisory sold 14 Johnson & Johnson shares in Q2 2026, an estimated $3.26K.
  • Johnson & Johnson made up 0.31% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #23 holding.
  • MJT & Associates Financial Advisory first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • MJT & Associates Financial Advisory's Johnson & Johnson position peaked at $624K in Q4 2025.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.